)
Eledon Pharmaceuticals (ELDN) investor relations material
Eledon Pharmaceuticals Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 18, 2026, at the company's Irvine, CA office.
Proxy materials, including the notice, proxy statement, and annual report, are available online for review and voting.
Voting matters and shareholder proposals
Election of three Class III directors: David-Alexandre C. Gros, M.D., Jan Hillson, M.D., and James Robinson.
Proposal to amend the Restated Certificate of Incorporation to increase authorized common stock from 300,000,000 to 450,000,000.
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Board of directors and corporate governance
Board recommends voting FOR all three proposals on the agenda.
- Shareholders will vote on director elections, share authorization, and auditor ratification.ELDN
Proxy filing1 May 2026 - Shareholders will vote on director elections, a share increase, and auditor ratification at the annual meeting.ELDN
Proxy filing21 Apr 2026 - Tegoprubart showed strong clinical progress and safety, with increased R&D driving a higher net loss.ELDN
Q4 202519 Mar 2026 - Tegoprubart advances with strong safety, phase 3 plans, and expanding transplant indications.ELDN
Leerink Global Healthcare Conference 202611 Mar 2026 - Promising transplant therapy advances to phase III, with expansion into islet and xenotransplant studies.ELDN
Guggenheim Securities Emerging Outlook: Biotech Summit 202612 Feb 2026 - Key phase 2 transplant data and strong financial runway position the program for major milestones.ELDN
Guggenheim Securities Inaugural Healthcare Innovation Conference14 Jan 2026 - Phase II kidney transplant data for tegoprubart expected Q4, aiming for superior efficacy and safety.ELDN
Guggenheim SMID Cap Biotech Conference29 Dec 2025 - Tegoprubart advances with strong transplant data, pivotal trials, and broad expansion plans in 2024.ELDN
Leerink’s Global Healthcare Conference 202518 Dec 2025 - Up to $250M in securities registered, including $75M ATM equity, to fund immunology pipeline and operations.ELDN
Registration Filing16 Dec 2025
Next Eledon Pharmaceuticals earnings date
Next Eledon Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)